By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Antibe Therapeutics Inc. 

1063 King St. West
Suite 210
Hamilton  Ontario  L8S 4S3  Canada
Phone: 905-515-6132 Fax: 905-528-9862


SEARCH JOBS


Industry
Biotechnology






Company News
Antibe Therapeutics (ATE.V) Engages Topstone Research And Appoints Dr Francis Chan As Key Advisor For Phase II Clinical Trial Of ATB-346 5/12/2017 6:12:41 AM
Antibe Therapeutics (ATE.V) Advances Development Of ATB-352 In Wake Of Growing Global Opioid Epidemic 4/26/2017 5:58:54 AM
Antibe Therapeutics (ATE.V) Provides Update On Clinical Development Program For Its Lead Drug, ATB-346 4/18/2017 6:11:01 AM
Antibe Therapeutics (ATE.V) Announces Grant Of Stock Options 4/3/2017 11:42:05 AM
Antibe Therapeutics (ATE.V) Announces Results Of Annual General Meeting 3/8/2017 7:03:25 AM
Antibe Therapeutics (ATE.V) Reports Q3 2017 Interim Financial And Operating Results 3/2/2017 6:52:15 AM
Antibe Therapeutics (ATE.V) Enters Into Regional Licensing Deal 2/24/2017 9:22:24 AM
Antibe Therapeutics (ATE.V) Engages MKR Group For U.S. Investor Relations 2/21/2017 6:29:55 AM
Antibe Therapeutics (ATE.V) Announces The Launch Of PentOS OI Max, Its Newest Bone Graft Substitute For Oral And Maxillofacial Surgery 1/31/2017 11:11:05 AM
Antibe Therapeutics (ATE.V) Release: Biotech Announces Change Of Auditor To Ernst & Young LLP 1/19/2017 8:25:42 AM
12345678
//-->